BACKGROUND: Resting heart rate has frequently been shown to be a predictor of coronary heart disease mortality. Elevated heart rate could also be a marker for the presence of other risk factors, which have not been taken into consideration in previous studies. OBJECTIVE: To evaluate the effect of resting heart rate on the risk of all-cause cardiovascular and cancer mortality, taking into consideration haematological variables. METHOD: The association between resting heart rate and mortality was assessed applying Cox's proportional hazard models to data obtained in an 8 year follow-up of 3527 Israeli male industrial employees. During this period 135 deaths were recorded, 57 from cardiovascular disease and 45 from cancer. Resting heart rate was assessed at entry; potential confounding demographic, anthropometric and socioeconomic variables, haematological data, serum lipid levels and health-related habits were accounted for. RESULTS: We found that the relative risk of all-cause mortality increased with increasing resting heart rate, workers with resting heart rate >90 beats. min(-1)had an adjusted relative risk of 2.23 (95% CI 1.4-3.6) compared with those with a heart rate <70 beats. min(-1). A similar result was achieved for cardiovascular disease mortality (adjusted relative risk 2.02, 95% CI 1.1-4.0). Cancer mortality was not associated with resting heart rate. CONCLUSION: This study found that resting heart rate is associated with all-cause and cardiovascular disease mortality after controlling (in various statistical models) for platelet counts, haemoglobin concentration, white blood cell counts, total protein, and other recognized risk factors. Copyright 2000 The European Society of Cardiology.
BACKGROUND: Resting heart rate has frequently been shown to be a predictor of coronary heart disease mortality. Elevated heart rate could also be a marker for the presence of other risk factors, which have not been taken into consideration in previous studies. OBJECTIVE: To evaluate the effect of resting heart rate on the risk of all-cause cardiovascular and cancer mortality, taking into consideration haematological variables. METHOD: The association between resting heart rate and mortality was assessed applying Cox's proportional hazard models to data obtained in an 8 year follow-up of 3527 Israeli male industrial employees. During this period 135 deaths were recorded, 57 from cardiovascular disease and 45 from cancer. Resting heart rate was assessed at entry; potential confounding demographic, anthropometric and socioeconomic variables, haematological data, serum lipid levels and health-related habits were accounted for. RESULTS: We found that the relative risk of all-cause mortality increased with increasing resting heart rate, workers with resting heart rate >90 beats. min(-1)had an adjusted relative risk of 2.23 (95% CI 1.4-3.6) compared with those with a heart rate <70 beats. min(-1). A similar result was achieved for cardiovascular disease mortality (adjusted relative risk 2.02, 95% CI 1.1-4.0). Cancer mortality was not associated with resting heart rate. CONCLUSION: This study found that resting heart rate is associated with all-cause and cardiovascular disease mortality after controlling (in various statistical models) for platelet counts, haemoglobin concentration, white blood cell counts, total protein, and other recognized risk factors. Copyright 2000 The European Society of Cardiology.
Authors: Mark Eijgelsheim; Christopher Newton-Cheh; Nona Sotoodehnia; Paul I W de Bakker; Martina Müller; Alanna C Morrison; Albert V Smith; Aaron Isaacs; Serena Sanna; Marcus Dörr; Pau Navarro; Christian Fuchsberger; Ilja M Nolte; Eco J C de Geus; Karol Estrada; Shih-Jen Hwang; Joshua C Bis; Ina-Maria Rückert; Alvaro Alonso; Lenore J Launer; Jouke Jan Hottenga; Fernando Rivadeneira; Peter A Noseworthy; Kenneth M Rice; Siegfried Perz; Dan E Arking; Tim D Spector; Jan A Kors; Yurii S Aulchenko; Kirill V Tarasov; Georg Homuth; Sarah H Wild; Fabio Marroni; Christian Gieger; Carmilla M Licht; Ronald J Prineas; Albert Hofman; Jerome I Rotter; Andrew A Hicks; Florian Ernst; Samer S Najjar; Alan F Wright; Annette Peters; Ervin R Fox; Ben A Oostra; Heyo K Kroemer; David Couper; Henry Völzke; Harry Campbell; Thomas Meitinger; Manuela Uda; Jacqueline C M Witteman; Bruce M Psaty; H-Erich Wichmann; Tamara B Harris; Stefan Kääb; David S Siscovick; Yalda Jamshidi; André G Uitterlinden; Aaron R Folsom; Martin G Larson; James F Wilson; Brenda W Penninx; Harold Snieder; Peter P Pramstaller; Cornelia M van Duijn; Edward G Lakatta; Stephan B Felix; Vilmundur Gudnason; Arne Pfeufer; Susan R Heckbert; Bruno H Ch Stricker; Eric Boerwinkle; Christopher J O'Donnell Journal: Hum Mol Genet Date: 2010-07-16 Impact factor: 6.150
Authors: Bayasgalan Gombojav; Hansoo Park; Jong Il Kim; Young Seok Ju; Joohon Sung; Sung Il Cho; Mi Kyeong Lee; Heechoul Ohrr; Janchiv Radnaabazar; Jeong Sun Seo Journal: Exp Mol Med Date: 2008-10-31 Impact factor: 8.718
Authors: Vincenzo De Santis; Domenico Vitale; Anna Santoro; Aurora Magliocca; Andrea Giuseppe Porto; Cecilia Nencini; Luigi Tritapepe Journal: Clin Res Cardiol Date: 2012-10-14 Impact factor: 5.460
Authors: Arpit Saxena; Dawn Minton; Duck-chul Lee; Xuemei Sui; Raja Fayad; Carl J Lavie; Steven N Blair Journal: Mayo Clin Proc Date: 2013-12 Impact factor: 7.616